Page 6 - Role of renal mass biopsy in the management of kidney cancer: KCRNC

Lavallée et al

4. De P, Otterstatter MC, Marrett LD, et al. Trends in incidence, mortality, and survival for kidney cancer in 25. Richard PO, Jewett MAS, Tanguay S, et al. Safety, reliability, and accuracy of small renal tumour biopsies:
Canada, 1986–2007. Cancer Causes Control 2014;25:1271-81. https://doi.org/10.1007/s10552- Results from a multi-institution registry. BJU Int 2017;119:543-9. https://doi.org/10.1111/bju.13630
014-0427-x 26. Kriegshauser JS, Patel MD, Young SW, et al. Factors contributing to the success of ultrasound-guided
5. Leveridge MJ, Finelli A, Kachura JR, et al. Outcomes of small renal mass needle core biopsy, non- native renal biopsy. J Ultrasound Med 2016;35:381-7. https://doi.org/10.7863/ultra.15.05023
diagnostic percutaneous biopsy, and the role of repeat biopsy. Euro Urol 2011;60:578-84. 27. Patel HD, Johnson MH, Pierorazio PM, et al. Diagnostic accuracy and risks of biopsy in the diagnosis
https://doi.org/10.1016/j.eururo.2011.06.021 of a renal mass suspicious for localized renal cell carcinoma: Systematic review of the literature. J Urol
6. Richard PO, Jewett MAS, Bhatt JR, et al. Renal tumor biopsy for small renal masses: A single-center 2016;195:1340-7. https://doi.org/10.1016/j.juro.2015.11.029
13-year experience. Eur Urol 2015;68:1007-13. https://doi.org/10.1016/j.eururo.2015.04.004 28. Prince J, Bultman E, Hinshaw L, et al. Patient and tumor characteristics can predict non-diagnostic renal
7. Marconi L, Dabestani S, Lam TB, et al. Systematic review and meta-analysis of diagnostic accu-Systematic review and meta-analysis of diagnostic accu - mass biopsy findings. J Urol 2015;193:1899-1904. https://doi.org/10.1016/j.juro.2014.12.021
racy of percutaneous renal tumor biopsy. Eur Urol 2016;69:660-73. https://doi.org/10.1016/j. 29. Macklin PS, Sullivan ME, Tapping CR, et al. Tumor seeding in the tract of percutaneous renal
eururo.2015.07.072 tumor biopsy: A report on seven cases from a UK tertiary referral center. Eur Urol 2019;75:861-7.
8. Lane B, Babineau D, Kattan M, et al. A preoperative prognostic nomogram for solid enhancing renal tumors https://doi.org/10.1016/j.eururo.2018.12.011
7 cm or less amenable to partial nephrectomy. J Urol 2007;178:429-34. https://doi.org/10.1016/j. 30. Brachemi S, Bollee G. Renal biopsy practice: What is the gold standard? World J Nephrol 2014;3:287-94.
juro.2007.03.106 https://doi.org/10.5527/wjn.v3.i4.287
9. Pahernik S, Ziegler S, Roos F, et al. Small renal tumors: Correlation of clinical and pathological features 31. Thrombosis Canada. Available at: https://thrombosiscanada.ca/guides/#. Published 2019. Accessed
with tumor size. J Urol 2007;178:414-7. https://doi.org/10.1016/j.juro.2007.03.129 April 10, 2019.
10. Bhindi B, Thompson RH, Lohse CM, et al. The probability of aggressive vs. indolent histology 32. Violette PD, Lavallée LT, Kassouf W, et al. Canadian Urological Association guideline on periop-Canadian Urological Association guideline on periop-
based on renal tumor size: Implications for surveillance and treatment. Eur Urol 2018;74:489-97. erative thromboprophylaxis and management of anticoagulation. Can Urol Assoc J 201913:105-14.
https://doi.org/10.1016/j.eururo.2018.06.003 https://doi.org/10.5489/cuaj.5828
11. Novick AC, Campbell SC, Belldegrun A, et al. Guideline for management of the clinical stage T1 renal 33. Kutikov A, Smaldone C, Egleston B, et al. Anatomic features of enhancing renal masses predict malig-
mass. J Urol 2009;182:1271-9. https://doi.org/10.1016/j.juro.2009.07.004 nant and high-grade pathology: A preoperative nomogram using the RENAL nephrometry score. Eur Urol
12. Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: AUA guideline. J Urol 2011;60:241-8. https://doi.org/10.1016/j.eururo.2011.03.029
2017;198:520-9. https://doi.org/10.1016/j.juro.2017.04.100 34. Organ M, MacDonald L, Jewett M, et al. Classification tree for the prediction of malignant disease and the
13. Ljungberg B, Albiges L, Bensalah K, et al. EAU guidelines on renal cell carcinoma 2018. Euro Urol prediction of non-diagnostic biopsies in patients with small renal masses. Can Urol Assoc J 2019;13:115-9.
2018;29:451-8. https://doi.org/10.5489/cuaj.5196
14. Jewett M, Rendon R, Lacombe L, et al. Canadian guidelines for the management of small renal masses 35. Jeldres C, Sun M, Liberman D, et al. Can renal mass biopsy assessment of tumor grade be safely substituted
(SRM). Can Urol Assoc J 2015;99:160-3. https://doi.org/10.5489/cuaj.2969 for by a predictive model? JURO 2009;182:2585-9. https://doi.org/10.1016/j.juro.2009.08.053
15. Thompson R, Kurta J, Kaag M, et al. Tumor size is associated with malignant potential in renal cell 36. Schmidbauer J, Remzi M, Memarsadeghi M, et al. Diagnostic accuracy of computed tomography-guided
carcinoma cases. J Urol 2009;181: 2033-6. https://doi.org/10.1016/j.juro.2009.01.027 percutaneous biopsy of renal masses. Eur Urol 2008;53:1003-12. https://doi.org/10.1016/j.
16. Rendon R, Kapoor A, Breau R, et al. Surgical management of renal cell carcinoma: Canadian Kidney eururo.2007.11.041
Cancer Forum Consensus. Can Urol Assoc J 2014;8:E398-412. https://doi.org/10.5489/cuaj.1894 37. Flum AS, Hamoui N, Said MA, et al. Update on the diagnosis and management of renal angiomyolipoma.
17. Lane BR, Demirjian S, Derweesh IH, et al. Survival and functional stability in chronic kidney disease J Urol 2016;195:834-46. https://doi.org/10.1016/j.juro.2015.07.126
due to surgical removal of nephrons: Importance of the new baseline glomerular filtration rate. Eur Urol 38. Dyer R, DiSantis DJ, McClennan BL, et al. Simplified imaging approach for evaluation of the solid renal
2015;68:996-1003. https://doi.org/10.1016/j.eururo.2015.04.043 mass in adults. Radiology 2008;247:331-43. https://doi.org/10.1148/radiol.2472061846
18. Jewett MAS, Mattar K, Basiuk J, et al. Active surveillance of small renal masses: Progression patterns of 39. Chandrasekar T, Ahmad A, Fadaak K, et al. Natural history of complex renal cysts: Clinical evidence
early stage kidney cancer. Eur Urol 2011;60:39-44. https://doi.org/10.1016/j.eururo.2011.03.030 supporting active surveillance. J Urol 2018;199:633-40. https://doi.org/10.1016/j.juro.2017.09.078
19. Pierorazio PM, Johnson MH, Ball MW, et al. Five-year analysis of a multi-institutional prospective clinical 40. Bhatt JR, Jewett MAS, Richard PO, et al. Multilocular cystic renal cell carcinoma: Pathological T stag-
trial of delayed intervention and surveillance for small renal masses: The DISSRM registry. Eur Urol ing makes no difference to favorable outcomes and should be reclassified. J Urol 2016;196:1350-5.
2015;68:408-15. https://doi.org/10.1016/j.eururo.2015.02.001 https://doi.org/10.1016/j.juro.2016.05.118
20. Cacciamani G, Medina L, Gill T, et al. Impact of surgical factors on robotic partial nephrec - 41. Huang H, Tamboli P, Karam JA. Secondary malignancies diagnosed using kidney needle core biopsies: A clin-
tomy outcomes: Comprehensive systematic review and meta-analysis. J Urol 2018;200:258-74. ical and pathological. Hum Pathol 2016;52:55-60. https://doi.org/10.1016/j.humpath.2015.12.028
https://doi.org/10.1016/j.juro.2017.12.086 42. Sheth S, Ali S, Fishman E. Imaging of renal lymphoma: Patterns of disease with pathologic correlation.
21. Richard PO, Martin L, Lavallée LT, et al. Identifying the use and barriers to the adoption of renal RadioGraphics 2006;26:1151-69. https://doi.org/10.1148/rg.264055125
tumour biopsy in the management of small renal masses. Can Urol Assoc J 2018;12:260-6. 43. Abel J, Culp S, Matin S, et al. Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to
https://doi.org/10.5489/cuaj.5065 predict high-risk pathologic features: Comparison with nephrectomy assessment. J Urol 2016;184:1877-
22. Richard PO, Lavallée LT, Pouliot F, et al. Is routine renal tumor biopsy associated with lower 81. https://doi.org/10.1016/j.juro.2010.06.105
rates of benign histology following nephrectomy for small renal masses? J Urol 2018;4:731-6. 44. Abel EJ, Carrasco A, Culp SH, et al. Limitations of preoperative biopsy in patients with metastatic
https://doi.org/10.1016/j.juro.2018.04.015 renal cell carcinoma: Comparison to surgical pathology in 405 cases. BJU Int 2012;110:1742-6.
23. Patel HD, Johnson MH, Pierorazio PM, et al. Diagnostic accuracy and risks of biopsy in the diagnosis https://doi.org/10.1111/j.1464-410X.2012.11124.x
of a renal mass suspicious for localized renal cell carcinoma: Systematic review of the literature. J Urol
2017;195:1340-7. https://doi.org/10.1016/j.juro.2015.11.029 Correspondence: Dr. Luke T. Lavallée, Division of Urology, The University of Ottawa, Ottawa, ON;
24. Tomaszewski JJ, Uzzo RG, Smaldone MC. Heterogeneity and renal mass biopsy: A review of its role and lulavallee@toh.ca
reliability rationale for expanded RMB indications. Cancer Biol Med 2014;11:162-72.

382 CUAJ • December 2019 • Volume 13, Issue 12